When drug patents expire, billions of dollars in revenues can disappear overnight as competitors enter the market. Accordingly, many investors focus on drug patents when evaluating drug companies. But, there…
The post Investing in Drug Companies? Here …
Investing in Drug Companies? Here are 6 Vital Non-Patent Factors to Consider Read Post »
Just because a drug has received FDA approval does not mean that it is available in the marketplace. But, why would a company go through all the trouble and expense…
The post Generic Drugs Approved but not Launched – How to Tell When Generic Drugs Will…
I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities for a Better ROI at the upcoming 13th Portfolio Management & Pipeline Optimization for Generics from September 30th…
The post Finding and Evaluating Market Entry Opportunities f…
Finding and Evaluating Market Entry Opportunities for a Better ROI Read Post »
The USPTO Office of the Chief Economist has releases a comprehensive set of patent litigation data files for public use. The Patent Litigation Dataset has been updated as of December…
The post Free Patent Litigation Docket Reports Data appeared first o…
The USPTO Office of the Chief Economist has releases a comprehensive set of patent litigation data files for public use. The Patent Litigation Dataset has been updated as of December…
The post Free Patent Litigation Docket Reports Data appeared first o…
The FDA Orange Book, or Approved Drug Products with Therapeutic Equivalence Evaluations, is the definitive source to link drugs with the patents that protect them. Over the years we’ve had…
The post Free Orange Book PDF Library from DrugPatentWatch app…
Free Orange Book PDF Library from DrugPatentWatch Read Post »
This article was originally published by Syed Sauban Ghani in Eclética Química under a Creative Commons license. ABSTRACT As scientific community worldwide is publishing a huge number of research articles…
The post A comprehensive review of database re…
A comprehensive review of database resources in chemistry Read Post »
This article was originally published by Mohammed M. Alshehri and Mahmoud M. E. Mudawi in the Journal of Pharmaceutical Research International under the terms of the Creative Commons Attribution License.…
The post Common Drugs with Effective Off-Label …
Check out this Bloomberg Law article where DrugPatentWatch shows how the number of patent challenges is increasing, while the number of challengers of each patent is also increasing. Why might this…
The post DrugPatentWatch and Bloomberg: Are there too…
DrugPatentWatch and Bloomberg: Are there too many generic patent challenges? Read Post »
Check out the latest issue of Lab Manager where I discuss my interest in informatics, the complexities of informatics for today’s scientists, and some of the tools available. https://www.labmanager.com/ask-the-expert/trends-in-informatics-22895
The pos…
Get new actionable insights and updates from BiotechBlog
